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Abstract
Introduction
Chronic conditions are the leading causes of death and disability
worldwide. Providing care to people diagnosed with a chronic dis-
ease is challenging, and controlling multiple chronic conditions
(MCCs) can be overwhelming, particularly in rapidly aging societ-
ies. The objective of this study was to examine the prevalence of
MCCs from 2000 to 2010 in Taiwan.
Methods
A random sample of 1 million representative National Health In-
surance beneficiaries in 3 years (2000, 2005, and 2010) was ob-
tained from the Taiwan National Health Insurance Research Data-
base to examine the prevalence of MCCs. Chronic Condition In-
dicator and Clinical Classifications Software were used to determ-
ine and classify codes from the International Classification of Dis-
eases,  Ninth  Revision.  People  who  had  2  or  more  conditions
among the 15 categories of conditions were defined as having
MCCs.
Results
The prevalence of MCCs increased from 9.6% in 2000 to 17.1% in
2010. The highest prevalence of MCCs was found among people
aged 65 years or older (42.3% in 2000 and 64.5% in 2010, a relat-
ive increase of 52.5%). However, the highest rate of increase was
found among people younger than 18 years (0.5% in 2000 and
1.6% in 2010, a relative increase of 220.0%).
Conclusion
MCCs are increasingly prevalent among the older (≥65 y) popula-
tion and among children and adolescents. Prevention and early in-
tervention programs targeted to certain age groups may be re-
quired. If the increase in MCCs continues rapidly, the manage-
ment of people diagnosed with MCCs would challenge the capa-
city of the health care system in Taiwan.
Introduction
Chronic conditions have become a major challenge to health care
systems in the 21st century (1,2). The challenge is especially great
among older people (those aged 65 or older); as people age, they
become more susceptible to developing chronic conditions (3).
Therefore, as the size of the older population increases, the preval-
ence of chronic conditions increases. Multiple chronic conditions
(MCCs) are associated with poor health outcomes, such as unne-
cessary hospitalizations, duplicate treatments, conflicting instruc-
tions, functioning disability, and mortality (1,2,4,5).
Providing appropriate care to people diagnosed with a chronic dis-
ease is challenging, and controlling MCCs can be overwhelming
for patients, families, providers, and society (6). People diagnosed
with MCCs may have more complex clinical needs and more of-
ten  receive  health  care  services  from multiple  providers  than
people diagnosed with 1 chronic condition (3). Development of in-
tegrated health care services has emerged as an essential issue and
a research priority to ensure the health of people diagnosed with
MCCs and the efficient use of health care resources (5,7–9).
A first step in confronting these challenges is to provide insights
into the scope of the population with MCCs (10). Several studies
examined the prevalence of MCCs in Australia, Canada, Europe,
and the United States (10–15). A recent review summarizing 33
population-based studies on multimorbidity in Australia, Canada,
the Netherlands, Spain, Sweden, and the United States found a
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prevalence of  MCCs ranging from 20% to 30% (1).  Although
much is  known about  the prevalence of  MCCs,  well-designed
studies on the trends in prevalence of MCCs are scarce.
Reports on the prevalence of MCCs are based primarily on cross-
sectional studies and restricted to the older population, which may
be problematic for generalizing findings to the overall population.
Evidence is mounting that although older people are at an espe-
cially high risk of MCCs, MCCs are also common among other
age groups. Although the prevalence of MCCs increases as age in-
creases, the absolute number of people diagnosed with MCCs is
high in people younger than 65 (12,16,17). One of the most critic-
al decisions in studying MCCs is the selection of conditions to be
assessed. The selection of 12 or more conditions may result in data
that do not show much variation (18). On the other hand, focusing
on a small number of conditions may underestimate the true bur-
den of MCCs. Diabetes, cardiovascular disease, hypertension, can-
cer, respiratory disease, joint disorders, and heart disease are the
conditions most commonly studied (19). Conditions commonly
found among younger people, such as eye disorders and digestive
diseases, are less likely to be studied. Data collected over time on
the prevalence of MCCs among the general population and all age
groups can show the temporal dynamics of MCCs and improve
our understanding of the magnitude of the burden.
A rapid increase in the percentage of older people and dramatic
lifestyle changes in several Asian countries leave these countries
with a short time to cope with the challenges of providing care to
people diagnosed with MCCs. Taiwan is an illustrative example: it
has one of  the fastest-growing older  populations in the world.
Taiwan’s older population might grow faster than European and
North  American  countries  and  surpass  Japan  to  become  the
world’s “most aged” country by 2033 (20,21). More empirical
evidence on changes in epidemiological patterns and MCCs is re-
quired to re-engineer the health care system in Taiwan, which was
originally designed to handle acute and episodic diseases.
The objective of this study was to investigate trends in the preval-
ence of MCCs in Taiwan using nationally representative cohorts
of National Health Insurance (NHI) beneficiaries.
Methods
This study was a descriptive cross-sectional analysis of preval-
ence estimates over time among age and sex categories in an Asi-
an population. Taiwan implemented the NHI program in March
1995; this program offers comprehensive health insurance cover-
age to all residents. The NHI program covered approximately 96%
of the population of 23.76 million by 2000, and today, more than
99% of the population is covered. The NHI maintains the Nation-
al Health Insurance Research Database, which contains enroll-
ment and claims data on use of inpatient, outpatient, and emer-
gency services and prescription drugs. For research purposes every
5 years, the National Health Research Institutes randomly samples
cohorts of 1 million NHI beneficiaries representative of the gener-
al Taiwanese population. For this study, we obtained data sets of 3
random samples of 1 million insurance beneficiaries in 3 years:
2000, 2005, and 2010. We excluded records for beneficiaries that
lacked information on age, sex, socioeconomic status (SES), or re-
gion of residence. We found no significant difference in age or sex
between the samples and all NHI beneficiaries (22).
We used the Chronic Condition Indicator (23) to determine Inter-
national Classification of Diseases, Ninth Revision (ICD-9) dia-
gnosis codes in the administrative data and to categorize ICD-9
diagnosis codes into 1 of 2 categories: chronic and nonchronic.
Clinical Classifications Software (CCS) (24) was used to classify
codes that indicated similar clinical characteristics into several
clinically meaningful categories (Appendix). Beneficiaries who
had at least 1 inpatient claim for a chronic condition and those
who made at least 3 outpatient visits classified with the same CCS
code for a chronic condition within 1 year were defined as pa-
tients that had a chronic condition.
There is no standard definition for MCCs. Many studies define
MCCs as 2 or more conditions, and some define MCCs as 3 or
more conditions. The use of 3 or more conditions may be more
meaningful for clinicians than a count of 2 or more when the study
population is older (18,25). Because our objective was to examine
trends in the prevalence of MCCs in the general population, we
chose to adopt the definition of 2 or more conditions. We also
chose to study the 15 most prevalent chronic conditions among the
study population (hepatitis, cancer, diabetes, hyperlipidemia, gout
and other crystal arthropathies, depression, eye disorders, nervous
system disorders, hypertension, heart disease, cerebrovascular dis-
ease, respiratory disease, digestive disease, genitourinary disease,
and joint disorder) to reflect the overall burden and to present a
comprehensive picture among all age groups. Our approach is the
approach most commonly used in various relevant studies (1,26).
The 15 chronic conditions selected are commonly selected in stud-
ies conducted in Taiwan (27,28). We also determined the 3 most
common types of dyads and triads by age groups; these dyads and
triads are not mutually exclusive (ie, an individual could be in
more than 1 dyad or triad).
Information on age, sex, SES, and region of residence was ob-
tained from the enrollment files. Age was classified into 5 categor-
ies: younger than 18 years, 18 to 24 years, 25 to 44 years, 45 to 64
years, and 65 years or older. SES was constructed on the basis of
the beneficiary’s insurable wages and occupation. NHI enrollment
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is mainly carried out through payroll deduction for people with
well-defined monthly wages and through tax payments for farm-
ers,  fishermen,  and others  not  having  a  well-defined  monthly
wage. SES for people with well-defined monthly wages was di-
vided into 3 categories: less than NT$ (Taiwanese new dollar)
20,000  (US$667),  NT$20,000  (US$667)  to  NT$39,999
(US$1,333), and more than NT$39,999 (US$1,333) per month.
Those without a well-defined monthly wage were farmers and
fishermen, local office beneficiaries, veterans; and low-income
people;  they were categorized as  “fixed amount.”  Dependents
were classified in the same category as the primary insured person.
Beneficiaries were classified according to geographical region in-
to 1 of 4 regions: northern, central, southern, and eastern. We de-
termined the distribution of demographic characteristics for each
sample according to the number of chronic conditions. To ascer-
tain cross-sectional prevalence over time in the general population,
we calculated the prevalence for each study year by dividing the
number of beneficiaries diagnosed with MCCs by the total num-
ber of beneficiaries for each year. The relative change in overall
MCC prevalence between 2000 and 2010 was calculated by divid-
ing the difference between the estimate for 2000 and 2010 by the
estimate for 2000 and expressed as a percentage. Age- and sex-
specific prevalence was also estimated. To assess trends in preval-
ence rates during the study period, we used the χ2 test and when
appropriate, the ptrend command in Stata (StataCorp LP). Statist-
ical analyses were conducted using Stata version 10.0 and SAS
version 9.2 (SAS Institute Inc). A P value less than .05 was con-
sidered significant.
Results
The final samples were 999,635 in 2000, 999,974 in 2005, and
999,998 in 2010 (Table 1). The mean age was 34.8 years in 2000,
36.4 years in 2005, and 38.7 years in 2010. The percentage of wo-
men increased from 48.6% in 2000 to 50.8% in 2010. The overall
prevalence of MCCs increased from 9.6% in 2000 to 13.5% in
2005 and 17.1% in 2010, a relative increase of 78.1%. The preval-
ence of MCCs in 4 categories (2 conditions, 3 conditions, 4 condi-
tions, or ≥5 conditions) also increased from 2000 to 2010 (Figure).
The relative increase in prevalence from 2000 to 2010 ranged
from 57.4% (for people with 2 conditions) to 121.0% (for people
with ≥5 conditions).
Figure.  Prevalence  of  multiple  chronic  conditions,  by  number  of  chronic
conditions among the general population in Taiwan in 2000, 2005, 2010.
Source of data: Taiwan National Health Insurance Research Database (22).
 
The prevalence of MCCs was higher among females than among
males in each study year. The overall  prevalence of MCCs in-
creased more among males (by 90.9%) than among females (by
67.3%) from 2000 to 2010. As expected, whereas 8.8% in 2000,
14.1% in 2005, and 17.1% in 2010 of those aged younger than 18
had at least 1 chronic condition, the prevalence was highest in
those aged 65 or older (58.3% in 2000, 75.1% in 2005, and 80.1%
in 2010). The greatest absolute increase in prevalence of MCCs
was found among those aged 65 or older (from 42.3% to 64.5%),
but  the  greatest  rate  of  increase  was  found among those  aged
younger  than  18  (from  0.5%  to  1.6%,  a  relative  increase  of
220.0%), followed by the rate of increase for these age groups: 18
to 24 (by 77.8%), 25 to 44 (by 75.0%), 65 or older (by 52.5%),
and 45 to 64 (by 35.4%).  By income group, the prevalence of
MCCs was lowest in the low-income group; the highest relative
increase was found in the middle-income group. We found the
largest  relative  and largest  absolute  increase  in  prevalence  of
MCCs among people residing in the eastern region.
The prevalence of MCCs varied according to age and sex (Table
2). We found a significant difference in the relative percentage
change from 2000 to 2010 in the prevalence of MCCs among men
(64.6%) and women (13.8%) aged 45 to 64. Whereas the preval-
ence of MCCs among men aged 45 to 64 increased significantly
from 16.1% in 2000 to 26.5% in 2010, the prevalence among wo-
men aged 45 to 64 women was stable. By contrast, the prevalence
of MCCs was similar for men and women aged 65 or older during
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the study period. The prevalence of MCCs among women aged 65
or older increased from 43.9% in 2000 to 65.9% in 2010, whereas
the prevalence among men in this age group from 40.8% in 2000
to 63.1% in 2010.
Among children and adolescents with 2 or more MCCs, the most
prevalent dyad was eye disorder/respiratory disease, followed by
respiratory disease/genitourinary disease, which was also the most
prevalent dyad for those aged 18 to 24 (Table 3); these combina-
tions increased in prevalence during the study period. The most
common co-occurring condition (in dyads) was genitourinary dis-
ease for those aged 25 to 44 and hypertension for those aged 45 or
older. Among children and adolescents who had at least 3 chronic
conditions, eye disorder/respiratory disease/genitourinary disease
was the leading combination in 2005, and its prevalence increased
in 2010. This triad was also one of the most prevalent among those
aged 18 to 24, and its prevalence also increased during the study
period. A common triad found among those aged 25 to 64 was dia-
betes/hyperlipidemia/hypertension; this triad more than doubled in
prevalence from 2000 to 2010. Diabetes/hypertension/heart dis-
ease was prevalent among those aged 45 or older, whereas hyper-
tension/heart disease/joint disorder was the most prevalent among
those 65 or older, and its prevalence was stable during the study
period.
Discussion
This study is one of the first population-based investigations of
trends in the prevalence of MCCs among all age groups of a gen-
eral population in Asia from 2000 to 2010. Based on the nation-
ally representative samples of nearly 1 million beneficiaries in
2000, 2005, and 2010, the prevalence of 2 or more chronic condi-
tions increased from 9.6% in 2000, to 13.5% in 2005 and 17.1% in
2010. Several factors may have contributed to the rise in MCCs,
including the natural outcomes of the aging process and an in-
crease in longevity among the Taiwanese. As people live longer,
their likelihood of developing a chronic condition increases, and
the duration of  disease lengthens.  The rise  in the estimates of
MCCs may also result from earlier and better detection of disease
— which may be caused by health care promotion activities and
an emerging public awareness of chronic conditions.
Most clinical guidelines for chronic diseases are principally de-
signed to treat diseases as if they occur in isolation. This study fur-
ther determined that the prevalence of MCCs surpassed the preval-
ence of single chronic conditions during the study period. This
finding illustrates the importance of MCCs in developing treat-
ment guidelines and reforming current clinical practices and health
care systems.
In this study, estimates of the prevalence of MCCs for each age
group were lower than estimates reported for Western populations.
This difference may be explained by differences in ethnicity and
lifestyle between Asian and Western populations (29). It is well
established  that  a  strong  association  exists  between  age  and
MCCs. Our study shows that the prevalence of at least 1 chronic
condition among those aged younger than 18 increased from 8.8%
to 17.1% from 2000 to 2010 and that more than half of people
who have MCCs in Taiwan were younger than 65. These findings
indicate that Taiwan must respond soon to the challenge of a rap-
id increase in the prevalence of MCCs.
Consistent with findings from other studies, our findings indicate
that the prevalence of MCCs among women is higher than the pre-
valence among men, regardless of age (2,13). The “survivor ef-
fect” may provide 1 explanation for the sex difference: the longer
life expectancy among women may put them at higher risk of ex-
posure to nonfatal chronic conditions. Sex differences in behavi-
ors of seeking health care may also explain sex differences in the
prevalence of MCCs. For example, women may be more likely
than men to use ambulatory care services; thus, their chronic con-
ditions may be detected more easily than those of men (1,30).
This study has several strengths. One, we used a nationally repres-
entative sample and a large sample size, which enabled us to gen-
eralize our findings and assess the prevalence of MCCs among
various age groups. Two, the NHI database allowed us to observe
prevalence over time. Three, we used a small number but a large
spectrum of chronic conditions recommended for measuring the
prevalence of MCCs (18). The prevalence of MCCs reported here
was based on a list of chronic conditions that included the most
prevalent conditions in Taiwan; thus, our findings are representat-
ive of the actual prevalence among the general population. Four,
our study gives a first insight into the trends in the most common
types of dyads and triads of chronic conditions by age group; un-
derstanding disease patterns over time for each age group is critic-
al. Five, our study not only highlights the disease combinations
that require the greatest health care but also serves as a direction
for the future design of best practice guidelines.
Our study has several limitations. One, by counting the number of
chronic conditions, we scored all conditions equally and did not
consider the severity of any condition. Two, our study was based
exclusively on administrative claims data; a limitation of claims
data is the potential unreliability of the information on diagnoses,
which may lead to misclassification and intentional or unintention-
al bias. We attempted to reduce such bias by adding strict criteria
to the definition of chronic conditions, and to minimize misclassi-
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fication, we included only patients who had at least 1 inpatient
claim and patients who had 3 outpatient diagnoses. Thus, the pre-
valence of MCCs measured in our study may be underestimated.
Despite these limitations, our study contributes to the literature by
presenting a comprehensive picture of the prevalence of MCCs
during 10 years. The aging of the baby-boomer population is ex-
pected to cause a large burden of MCCs. Several Asian countries,
including Taiwan, provide examples of such rapidly aging baby-
boomer  populations.  As  greater  numbers  of  older  people  live
longer, and as lifestyles continue to modernize, a rise in the pre-
valence of MCCs is foreseen. We also foresee a rise among the
younger population. The increasing prevalence of MCCs chal-
lenges the health care system to provide timely and appropriate
care. Knowledge about disease patterns can help optimize prevent-
ive strategies and early recognition of concurrent conditions. Fur-
ther research is required to improve understanding of MCCs and
organize health care systems for people who have them.
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Tables
Table 1. Selected Demographic Characteristics of Samples, by Number of Chronic Conditions in 2000, 2005, and 2010, Taiwana,b
Characteristic
2000 (N = 999,635) 2005 (N = 999,974) 2010 (N = 999,998)
P Valuec
No. of Chronic Conditions No. of Chronic Conditions No. of Chronic Conditions
1 2–5 >5 1 2–5 >5 1 2–5 >5
No. of people 118,118 91,924 4,062 150,196 128,256 7,134 158,351 161,139 9,658 —
Overall prevalence 11.8 9.2 0.4 15.0 12.8 0.7 15.8 16.1 1.0 <.001
Sex
Female 14.0 10.0 0.4 17.1 13.3 0.7 18.0 16.5 0.9 <.001
Male 9.7 8.4 0.4 12.9 12.4 0.8 13.6 15.7 1.1 <.001
Mean age, y 40.4 60.3 69.8 39.3 60.3 71.1 40.1 60.8 71.7 —
Age group
<18 y 8.3 0.5 0.0 13.0 1.1 0.0 15.5 1.6 0.0 <.001
18–24 y 8.0 0.9 0.0 11.3 1.5 0.0 11.3 1.6 0.0 <.001
25–44 y 10.8 3.2 0.0 14.0 4.7 0.0 14.9 5.6 0.0 <.001
45–64 y 17.8 19.0 0.5 18.8 22.0 0.7 18.8 25.5 0.9 <.001
≥65 y 16.0 39.4 2.9 17.4 52.6 5.1 15.6 58.4 6.1 <.001
Socioeconomic statusd
<$20,000 10.5 6.1 0.2 14.1 8.1 0.3 14.2 7.7 0.3 <.001
$20,000–$39,999 12.0 7.0 0.2 15.4 10.5 0.4 16.6 13.2 0.6 <.001
≥40,000 13.3 9.1 0.3 15.9 12.0 0.5 17.2 15.7 0.7 <.001
Fixed 12.4 14.6 0.8 15.0 19.4 1.5 14.7 23.9 1.9 <.001
Region
Northern 11.5 8.6 0.4 14.5 11.9 0.6 15.4 15.1 0.9 <.001
Central 11.8 9.1 0.4 15.6 12.7 0.6 16.5 16.0 0.9 <.001
Southern 12.3 10.2 0.5 15.7 14.4 0.9 16.3 17.8 1.1 <.001
Eastern 11.9 11.0 0.4 14.6 15.6 0.8 15.2 20.0 1.3 <.001
Abbreviations: N, number; SES, socioeconomic status.
a Three sets of random samples of National Health Insurance beneficiaries were obtained from the Taiwan National Health Insurance Research Database (22).
b All values are percentages unless otherwise indicated.
c The trend for 2 to 5 chronic conditions was tested by χ2.
d Socioeconomic status was constructed on the basis of the beneficiary’s insurable wages and occupation. For people with well-defined monthly wages, it was di-
vided into 3 categories: less than NT$ (Taiwanese new dollar) 20,000, NT$20,000 to NT$39,999, and more than NT$39,999. Those without a well-defined
monthly wage were farmers and fishermen, local office beneficiaries, veterans; and low-income people; they were categorized as “fixed amount.”
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Table 2. Age- and Sex-Specific Prevalence of Multiple Chronic Conditions in 2000, 2005, and 2010, Taiwana
Age and
Sex
2000 2005 2010 Relative
Change From
2000 to
2010, %
P for
TrendSample, n Prevalence, n (%)
Sample,
n Prevalence, n (%)
Sample,
n Prevalence, n (%)
Female
<18 y 109,698 484 (0.4) 101,358 976 (1.0) 86,668 1,236 (1.4) 223.2 <.001
18–24 y 58,289 650 (1.1) 53,950 918 (1.7) 47,795 989 (2.1) 85.6 <.001
25–44 y 171,931 5,836 (3.4) 175,831 8,134 (4.6) 173,037 9,633 (5.6) 64.0 <.001
45–64 y 97,768 22,496 (23.0) 119,202 28,490 (23.9) 139,687 36,588 (26.2) 13.8 <.001
≥65 y 48,286 21,173 (43.9) 53,829 31,660 (58.8) 60,388 39,780 (65.9) 50.2 <.001
All 485,972 50,639 (10.4) 504,170 70,178 (13.9) 507,575 88,226 (17.4) 66.8 <.001
Male
<18 y 119,158 714 (0.6) 110,855 1,327 (1.2) 95,091 1,585 (1.7) 178.2 <.001
18–24 y 61,327 386 (0.6) 47,296 574 (1.2) 45,007 493 (1.1) 74.0 <.001
25–44 y 178,396 5,572 (3.1) 166,698 7,980 (4.8) 159,359 8,981 (5.6) 80.4 <.001
45–64 y 99,120 15,944 (16.1) 117,483 25,098 (21.4) 137,195 36,316 (26.5) 64.6 <.001
≥65 y 55,662 22,731 (40.8) 53,472 30,233 (56.5) 55,771 35,196 (63.1) 54.5 <.001
All 513,663 45,347 (8.8) 495,804 65,212 (13.2) 492,423 82,571 (16.8) 89.9 <.001
a Three sets of random samples of National Health Insurance beneficiaries were obtained from the Taiwan National Health Insurance Research Database (22).
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Table 3. Most Prevalent Dyads of Chronic Conditions Among People With 2 or More Chronic Conditions and Most Prevalent Triads
Among People With 3 or More Chronic Conditions, by Age Group in 2000, 2005, and 2010, Taiwana,b
Age Group 2000 2005 2010
Dyads
<18 y Eye/Resp 667 (55.7) Eye/Resp 1,434 (62.3) Eye/Resp 1,783 (63.2)
Resp/Genito 114 (9.5) Resp/Genito 233 (10.1) Resp/Genito 271 (9.6)
Resp/Digest 102 (8.5) Resp/Digest 191 (8.3) Resp/Digest 209 (7.4)
18–24 y Resp/Genito 137 (13.2) Resp/Genito 288 (19.3) Resp/Genito 336 (22.7)
Eye/Genito 94 (9.1) Eye/Genito 142 (9.5) Eye/Resp 158 (10.7)
Eye/Resp 71 (6.9) Eye/Resp 116 (7.8) Eye/Genito 129 (8.7)
25–44 y Hepa/Digest 836 (7.3) Resp/Genito 1,388 (8.6) Resp/Genito 1,837 (9.9)
Depress/Digest 803 (7.0) HLD/HTN 1,088 (6.8) HLD/HTN 1,747 (9.4)
Resp/Genito 704 (6.2) Hepa/Digest 1,022 (6.3) Diabetes/HLD 1,508 (8.1)
45–64 y Genito/Joint 5,739 (14.9) Diabetes/HTN 8,842 (16.5) HLD/HTN 16,130 (22.1)
Diabetes/HTN 5,006 (13.0) HLD/HTN 8,504 (15.9) Diabetes/HTN 13,962 (19.2)
HTN/Heart 4,911 (12.8) HTN/Heart 7,301 (13.6) Diabetes/HLD 11,900 (16.3)
≥65 y HTN/Heart 10,632 (24.2) HTN/Heart 15,400 (24.9) Diabetes/HTN 18,521 (24.7)
HTN/Joint 8,260 (18.8) HTN/Joint 13,127 (21.2) HTN/Heart 18,334 (24.5)
Diabetes/ HTN 7,800 (17.8) Diabetes/HTN 13,084 (21.1) HTN/Joint 16,678 (22.2)
Triads
<18 y Depress/Resp/Digest 3 (6.5) Eye/Resp/Genito 20 (17.7) Eye/Resp/Genito 29 (20.9)
Depress/Digest/Genito 3 (6.5) Eye/Resp/Digest 17 (15.0) Eye/Resp/Digest 17 (12.2)
Heart/Resp/Digest 3 (6.5) Resp/Digest/Genito 8 (7.1) Depress/Eye/Resp 13 (9.4)
18–24 y Depress/Resp/Digest 8 (6.4) Depress/Resp/Genito 18 (8.2) Eye/Resp/Genito 20 (9.5)
Eye/Resp/Genito 8 (6.4) Eye/Resp/Genito 17 (7.7) Resp/Digest/Genito 14 (6.6)
Hepa/HLD/Gout 7 (5.6) Hepa/HLD/Gout 12 (5.5) Depress/Resp/Digest 12 (5.7)
25–44 y Diabetes/HLD/HTN 123 (3.7) Diabetes/HLD/HTN 272 (5.6) Diabetes/HLD/HTN 562 (9.6)
Depress/HTN/Heart 114 (3.4) HLD/Gout/HTN 190 (3.9) HLD/Gout/HTN 263 (4.5)
Hepa/Depress/Digest 113 (3.4) HLD/HTN/Heart 187 (3.9) HLD/HTN/Heart 221 (3.8)
45–64 y HTN/Genito/Joint 1,274 (6.8) Diabetes/HLD/HTN 3,344 (12.1) Diabetes/HLD/HTN 6,619 (16.7)
Diabetes/HLD/HTN 1,220 (6.6) HLD/HTN/Heart 1,963 (7.1) HLD/HTN/Heart 3,240 (8.2)
Diabetes/HTN/Heart 1,078 (5.8) Diabetes/HTN/Heart 1,761 (6.4) Diabetes/HTN/Heart 2,394 (6.0)
≥65 y HTN/Heart/Joint 3,039 (10.7) HTN/Heart/Joint 4,642 (10.9) Diabetes/HLD/HTN 6,488 (12.1)
HTN/Heart/Resp 2,641 (9.3) Diabetes/HTN/Heart 4,247 (10.0) HTN/Heart/Joint 5,704 (10.7)
Diabetes/HTN/Heart 2,574 (9.1) Eye/HTN/Heart 3,934 (9.2) Diabetes/HTN/Heart 5,584 (10.5)
Abbreviations: Eye, eye disorder; Resp, respiratory disease; Genito, genitourinary disease; Digest, digestive disease; Hepa, hepatitis; Depress, depression; HLD, hy-
perlipidemia; HTN, hypertension; Joint, joint disorder; Heart, heart disease; Gout, gout and other crystal arthropathies.
a All values are number (percentage).
b Three sets of random samples of National Health Insurance beneficiaries were obtained from the Taiwan National Health Insurance Research Database (22).
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Appendix. Selection of 15 Chronic Conditions by Clinical Classification Software (CCS) Code
Chronic Condition CCS code
Hepatitis 1.3
Cancer 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 2.10, 2.11, 2.12, 2.13, 2.14, 2.15, 2.16
Diabetes 3.2, 3.3
Hyperlipidemia 3.6
Gout and other crystal arthropathies 3.7
Depression 5.2, 5.8
Eye disorder 6.7
Nervous system disorders 6.9
Hypertension 7.1
Heart disease 7.2
Cerebrovascular disease 7.3
Respiratory disease 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.7, 8.8, 8.9
Digestive disease 9.1, 9.2, 9.3, 9.4, 9.5, 9.6, 9.7, 9.8, 9.9, 9.10, 9.11, 9.12
Genitourinary disease 10.1, 10.2, 10.3
Joint disorder 13.2, 13.3, 13.4
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